Trial intelligence / Profile preview

Intra-articular Injection of Type I Atelocollagen to Alleviate Knee Pain

NCT02539095Phase 4Completed

Sponsor
Cellontech
Start
Apr 2014
Primary completion
Aug 2015
Countries
1
01

Overview

A Phase 4 trial of DPS-004 in osteoarthritis (OA), Post-traumatic arthritis (PTA), sponsored by Cellontech. Started Apr 2014; status: completed.

02

Drugs

DPS-004
03

Conditions

osteoarthritis (OA)Post-traumatic arthritis (PTA)

Beyond the preview

Go deeper on NCT02539095.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02539095.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call